Almirall Delivers Strong Start of 2024 – Q1 Net Sales Growth of 6.6% Overall and 18% in the European Dermatology Business, Driven by Biologics and Solid Performance of Broad Product Portfolio

By /

Almirall, S.A. a global biopharmaceutical company based in Barcelona, announced its financial results from the first quarter 2024.

Scroll to Top